Postural orthostatic tachycardia syndrome (POTS) is a disorder of the autonomic nervous system that affects the body’s ability to regulate its heart rate and blood pressure in response to changes in body position. This syndrome is still relatively unknown, yet it affects an estimated 500,000 to 3 million Americans. POTS is a complex disorder that is often misdiagnosed or overlooked, leading to a lack of understanding and treatment options. This article aims to provide an overview of POTS, its symptoms, diagnosis, treatment options, and resources available to patients and healthcare providers.
Postural orthostatic tachycardia syndrome (POTS) is a disorder of the autonomic nervous system. It is characterized by an excessive increase in heart rate when a person stands up from a lying or sitting position. This increase in heart rate is typically greater than 30 beats per minute (bpm) or an increase of more than 120 bpm within 10 minutes of standing. The autonomic nervous system is responsible for controlling involuntary body functions such as heart rate, blood pressure, digestion, and temperature regulation. In people with POTS, the autonomic nervous system does not respond properly to changes in body position.
The most common symptom of POTS is an increase in heart rate when standing. Other symptoms include lightheadedness, dizziness, fatigue, shortness of breath, chest pain, and palpitations. POTS can also cause a variety of other symptoms such as headaches, nausea, blurred vision, sweating, and fainting.
The diagnosis of POTS is based on a combination of symptoms, physical examination, and laboratory tests. The most commonly used laboratory test is a tilt table test. This test measures the heart rate and blood pressure before and after a person stands up. A diagnosis of POTS is made if the heart rate increases by 30 bpm or more, or if the blood pressure drops by more than 20 mmHg when standing. Other tests such as an electrocardiogram (ECG) and echocardiogram (ECHO) may also be used to rule out other conditions.
The treatment of POTS is focused on symptom relief and improving quality of life. The most common treatment is lifestyle modifications such as increasing salt and fluid intake, avoiding triggers (such as caffeine and alcohol), and exercising regularly. Medications such as beta blockers, midodrine, and fludrocortisone may also be used to help reduce symptoms. In some cases, physical therapy and orthostatic training may be helpful.
There are a number of resources available to both patients and healthcare professionals to help increase understanding and awareness of POTS. The Dysautonomia International website provides information about POTS, including diagnosis, treatment, and research. The American Autonomic Society also provides resources for healthcare professionals. Additionally, there are a number of support groups and online forums available for patients to connect with others who have POTS.
Postural orthostatic tachycardia syndrome (POTS) is a disorder of the autonomic nervous system that affects the body’s ability to regulate its heart rate and blood pressure in response to changes in body position. While POTS is still relatively unknown, it affects an estimated 500,000 to 3 million Americans. Despite its prevalence, POTS is often misdiagnosed or overlooked, leading to a lack of understanding and treatment options. This article has provided an overview of POTS, its symptoms, diagnosis, treatment options, and resources available to patients and healthcare providers. With increased awareness and understanding of POTS, patients can receive the diagnosis and treatment they need to improve their health and quality of life.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation